Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.40 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.39 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 2/20 | 0.39 |
| ▸ | MERTK | Q12866 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9205951 | 0.74 | TRPM8 (0.53) | MERTKCNR1CNR2 | |
| SCHEMBL5030703 | 0.73 | PKM (0.48) | ALDH1A1L3MBTL1CYP2D6CYP2C19NOS1 | |
| SCHEMBL14869399 | 0.72 | SMN1; SMN2 (0.58) | ALDH1A1DHFRSMN1; SMN2RAB9A | |
| SCHEMBL14266667 | 0.69 | TSHR (0.57) | ALDH1A1CNR1CNR2 | |
| SCHEMBL18855572 | 0.69 | TRPM8 (0.45) | CNR1CNR2RAB9A | |
| SCHEMBL15094943 | 0.69 | ADORA2A (0.47) | L3MBTL1SMN1; SMN2 | |
| SCHEMBL4829081 | 0.68 | CTSL (0.60) | L3MBTL1CYP2D6CYP2C19MERTKSMN1; SMN2 | |
| SCHEMBL14869432 | 0.67 | SMN1; SMN2 (0.52) | ALDH1A1DHFRSMN1; SMN2RAB9A | |
| SCHEMBL795874 | 0.66 | SMN1; SMN2 (0.58) | ALDH1A1DHFRSMN1; SMN2RAB9A | |
| SCHEMBL19390961 | 0.66 | HRH3 (0.70) | ALDH1A1L3MBTL1CYP2D6CYP2C19CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040077648-A1 | Methods and compositions of novel triazine compounds | DR. REDDY'S LABORATORIES LTD. (IN) | 2004-04-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077648-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | ALDH1A1 4407/4885L3MBTL1 4810/4885CYP2D6 4839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.